Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Establishment and characterization of atypical fibroblasts from human adult liver contributing to hepatocyte cord-like arrangement.

Jodon de Villeroché V, Brouty-Boyé D.

Cell Biol Int. 2008 Jun;32(6):605-14. doi: 10.1016/j.cellbi.2008.01.003. Epub 2008 Jan 25.

PMID:
18296076
2.

Developmental biology of fibroblasts and neoplastic disease.

Brouty-Boyé D.

Prog Mol Subcell Biol. 2005;40:55-77. Review. No abstract available.

PMID:
17153480
3.

Co expression of SCF and KIT in gastrointestinal stromal tumours (GISTs) suggests an autocrine/paracrine mechanism.

Théou-Anton N, Tabone S, Brouty-Boyé D, Saffroy R, Ronnstrand L, Lemoine A, Emile JF.

Br J Cancer. 2006 Apr 24;94(8):1180-5.

4.

Report on antibodies submitted to the stromal cell section of HLDA8.

Buckley CD, Halder S, Hardie D, Reynolds G, Torensma R, De Villeroche VJ, Brouty-Boye D, Isacke CM.

Cell Immunol. 2005 Jul-Aug;236(1-2):29-41. Epub 2005 Sep 19.

5.

Membrane-bound and soluble IL-15/IL-15Ralpha complexes display differential signaling and functions on human hematopoietic progenitors.

Giron-Michel J, Giuliani M, Fogli M, Brouty-Boyé D, Ferrini S, Baychelier F, Eid P, Lebousse-Kerdilès C, Durali D, Biassoni R, Charpentier B, Vasquez A, Chouaib S, Caignard A, Moretta L, Azzarone B.

Blood. 2005 Oct 1;106(7):2302-10. Epub 2005 Jun 23.

PMID:
15976182
6.

Human bronchial fibroblasts exhibit a mesenchymal stem cell phenotype and multilineage differentiating potentialities.

Sabatini F, Petecchia L, Tavian M, Jodon de Villeroché V, Rossi GA, Brouty-Boyé D.

Lab Invest. 2005 Aug;85(8):962-71.

7.
8.

Inflammatory status and cartilage regenerative potential of synovial fibroblasts from patients with osteoarthritis and chondropathy.

Fiorito S, Magrini L, Adrey J, Mailhé D, Brouty-Boyé D.

Rheumatology (Oxford). 2005 Feb;44(2):164-71. Epub 2004 Oct 12.

PMID:
15479753
9.

Does cytogenetic mosaicism in CD34+CD38low cells reflect the persistence of normal primitive hematopoietic progenitors in myeloid metaplasia with myelofibrosis?

Bilhou-Nabéra C, Brigaudeau C, Clay D, Andrieux J, Lai JL, Brouty-Boyé D, Vignon C, Gharbi MJ, Le Bousse-Kerdilès MC, Praloran V; French INSERM Network o Myeloid Metaplasia with Myelofibrosis.

Blood. 2003 Aug 15;102(4):1551-2. No abstract available.

PMID:
12900353
10.

Impaired NK cell differentiation of blood-derived CD34+ progenitors from patients with myeloid metaplasia with myelofibrosis.

Briard D, Brouty-Boyé D, Giron-Michel J, Azzarone B, Jasmin C, Le Bousse-Kerdilès C.

Clin Immunol. 2003 Mar;106(3):201-12.

PMID:
12706407
11.

Detection of a functional hybrid receptor gammac/GM-CSFRbeta in human hematopoietic CD34+ cells.

Giron-Michel J, Fogli M, Gaggero A, Ferrini S, Caignard A, Brouty-Boye D, Baouz S, Le Bousse-Kerdiles MC, Peault B, van Dijk M, Bulfone-Paus S, Durali D, Chouaib S, Azzarone B.

J Exp Med. 2003 Mar 17;197(6):763-75.

12.

Differential STAT3, STAT5, and NF-kappaB activation in human hematopoietic progenitors by endogenous interleukin-15: implications in the expression of functional molecules.

Giron-Michel J, Caignard A, Fogli M, Brouty-Boyé D, Briard D, van Dijk M, Meazza R, Ferrini S, Lebousse-Kerdilès C, Clay D, Bompais H, Chouaib S, Péault B, Azzarone B.

Blood. 2003 Jul 1;102(1):109-17. Epub 2003 Mar 6.

PMID:
12623850
13.

Fibroblasts from human spleen regulate NK cell differentiation from blood CD34(+) progenitors via cell surface IL-15.

Briard D, Brouty-Boyé D, Azzarone B, Jasmin C.

J Immunol. 2002 May 1;168(9):4326-32.

14.

Effects of human fibroblasts from myelometaplasic and non-myelometaplasic hematopoietic tissues on CD34+ stem cells.

Brouty-Boyé D, Briard D, Azzarone B, Le Bousse-Kerdilès MC, Clay D, Pottin-Clémenceau C, Jasmin C.

Int J Cancer. 2001 May 15;92(4):484-8.

15.

Chemokines and CD40 expression in human fibroblasts.

Brouty-Boyé D, Pottin-Clémenceau C, Doucet C, Jasmin C, Azzarone B.

Eur J Immunol. 2000 Mar;30(3):914-9.

16.

IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts.

Doucet C, Brouty-Boyé D, Pottin-Clemenceau C, Jasmin C, Canonica GW, Azzarone B.

Int Immunol. 1998 Oct;10(10):1421-33.

PMID:
9796908
17.

IL-15 is produced by a subset of human melanomas, and is involved in the regulation of markers of melanoma progression through juxtacrine loops.

Barzegar C, Meazza R, Pereno R, Pottin-Clemenceau C, Scudeletti M, Brouty-Boyé D, Doucet C, Taoufik Y, Ritz J, Musselli C, Mishal Z, Jasmin C, Indiveri F, Ferrini S, Azzarone B.

Oncogene. 1998 May 14;16(19):2503-12.

18.

Phenotypic diversity in human fibroblasts from myelometaplasic and non-myelometaplasic hematopoietic tissues.

Brouty-Boyé D, Doucet C, Clay D, Le Bousse-Kerdiles MC, Lampidis TJ, Azzarone B.

Int J Cancer. 1998 May 29;76(5):767-73.

19.

Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma.

Doucet C, Brouty-Boyé D, Pottin-Clémenceau C, Canonica GW, Jasmin C, Azzarone B.

J Clin Invest. 1998 May 15;101(10):2129-39.

20.

Role of interleukin (IL)-2 and IL-15 in the tumour progression of a melanoma cell line MELP, derived from an IL-2 progressor patient.

Doucet C, Meazza R, Pottin-Clemenceau C, Scudeletti M, Brouty-Boye D, Ferrini S, Alileche A, Taoufik Y, Jasmin C, Azzarone B, Indiveri F.

Melanoma Res. 1997 Aug;7 Suppl 2:S7-17.

PMID:
9578412
21.

Discrimination of fibroblast subtypes by multivariate analysis of gene expression.

Spanakis E, Brouty-Boyé D.

Int J Cancer. 1997 May 2;71(3):402-9.

22.

On the distribution of insulin-like growth factors in breast tissues.

Spanakis E, Brouty-Boyé D.

Int J Cancer. 1996 Nov 15;68(4):555-6. No abstract available.

23.

IL2 triggers a tumor progression process in a melanoma cell line MELP derived from a patient whose metastasis increased in size during IL2/INFalpha biotherapy.

Han D, Pottin-Clemenceau C, Imro MA, Scudeletti M, Doucet C, Puppo F, Brouty-Boye D, Vedrenne J, Sahraoui Y, Brailly H, Poggi A, Jasmin C, Azzarone B, Indiveri F.

Oncogene. 1996 Mar 7;12(5):1015-23.

PMID:
8649792
24.

Quantitative variation of proto-oncogene and cytokine gene expression in isolated breast fibroblasts.

Spanakis E, Brouty-Boyé D.

Int J Cancer. 1995 May 29;61(5):698-705. Erratum in: Int J Cancer 1995 Nov 15;63(4):609.

PMID:
7768644
25.
26.

Antiproliferative activity of taxol on human tumor and normal breast cells vs. effects on cardiac cells.

Brouty-Boye D, Kolonias D, Lampidis TJ.

Int J Cancer. 1995 Feb 8;60(4):571-5.

PMID:
7829273
27.

Evaluation of quantitative variation in gene expression.

Spanakis E, Brouty-Boyé D.

Nucleic Acids Res. 1994 Mar 11;22(5):799-806.

28.

Fibroblast-mediated differentiation in human breast carcinoma cells (MCF-7) grown as nodules in vitro.

Brouty-Boyé D, Mainguené C, Magnien V, Israel L, Beaupain R.

Int J Cancer. 1994 Mar 1;56(5):731-5.

PMID:
8314351
30.
31.

"Normal" breast cells adjacent to a tumor grown in long-term three-dimensional culture.

Beaupain R, Mainguené C, Brouty-Boyé D, Planchon P, Magnien V.

In Vitro Cell Dev Biol. 1993 Feb;29A(2):100-4. No abstract available.

PMID:
8473264
32.

Differential effects of butyrate derivatives on human breast cancer cells grown as organotypic nodules in vitro and as xenografts in vivo.

Planchon P, Magnien V, Beaupain R, Mainguene C, Ronco G, Villa P, Brouty-Boye D.

In Vivo. 1992 Nov-Dec;6(6):605-10.

PMID:
1296809
33.

Morphology and intermediate filament composition of human mammary epithelial cells treated with stable butyrate derivative.

Planchon P, Magnien V, Ronco G, Villa P, Brouty-Boye D.

Anticancer Res. 1992 Nov-Dec;12(6B):2315-20.

PMID:
1284203
34.

Immunophenotype of SV40-T gene transfected epithelial cell lines derived from human benign breast tumors.

Raux H, Planchon P, Chraibi-Hajji F, Magnien V, Sallé V, Brouty-Boyé D.

In Vitro Cell Dev Biol. 1992 Jul-Aug;28A(7-8):468-70. No abstract available.

PMID:
1381707
35.

Role of endogenous interferon in the high sensitivity of C3H/10T1/2 cells to the antiviral activity of interferon.

Wybier-Franqui J, Brouty-Boyé D.

J Interferon Res. 1992 May;Spec No:17-22.

PMID:
1379282
36.

Alpha-smooth muscle actin expression in cultured cardiac fibroblasts of newborn rat.

Brouty-Boye D, Kolonias D, Savaraj N, Lampidis TJ.

In Vitro Cell Dev Biol. 1992 Apr;28A(4):293-6.

PMID:
1583007
37.

New stable butyrate derivatives alter proliferation and differentiation in human mammary cells.

Planchon P, Raux H, Magnien V, Ronco G, Villa P, Crépin M, Brouty-Boyé D.

Int J Cancer. 1991 May 30;48(3):443-9.

PMID:
2040538
38.

Fetal myofibroblast-like cells isolated from post-radiation fibrosis in human breast cancer.

Brouty-Boyé D, Raux H, Azzarone B, Tamboise A, Tamboise E, Béranger S, Magnien V, Pihan I, Zardi L, Israël L.

Int J Cancer. 1991 Mar 12;47(5):697-702.

PMID:
2004850
39.

Steroid hormone receptors and tumorigenicity of sublines from breast tumor metastatic MDA-MB 231 cell line.

Crépin M, Salle V, Raux H, Berger R, Hamelin R, Brouty-Boyé D, Israel L.

Anticancer Res. 1990 Nov-Dec;10(6):1661-6.

PMID:
2285240
40.

Accelerated malignant conversion of human HBL-100 cells by the v-Ki-ras oncogene.

Saint-Ruf C, Nardeux P, Estrade S, Brouty-Boye D, Lavialle C, Rhim JS, Cassingena R.

Exp Cell Res. 1988 May;176(1):60-7.

PMID:
2836229
41.

Retinoic acid or methionine enhance interferon's inhibition of the transformed phenotype with no effect on tumorigenicity.

Brouty-Boyé D, Lejealle R.

J Biol Regul Homeost Agents. 1988 Jan-Mar;2(1):45-9.

PMID:
3177023
42.

Karyotype evolution of the human HBL-100 cell line and mapping of the integration site of SV40 DNA.

Marlhens F, Saint-Ruf C, Nardeux P, Lavialle C, Brouty-Boye D, Dutrillaux B, Cassingena R.

Ann Genet. 1988;31(2):81-6.

PMID:
2840847
43.

Effects of interferons alpha,beta,gamma alone or in combination on the phenotype of human colon carcinoma cells.

Brouty-Boyé D, Maunoury MT, Lowy R.

Anticancer Res. 1988 Jan-Feb;8(1):197-203.

PMID:
2451894
44.

Interferon-induced phenotypic changes in human tumor cells relative to the effects of interferon on c-ras oncogene expression.

Brouty-Boyé D, Wybier-Franqui J, Nardeux P, Daya-Grosjean L, Andeol Y, Suarez HG.

J Interferon Res. 1986 Oct;6(5):461-71.

PMID:
2433360
45.

Interferon and the tumour cell phenotype.

Brouty-Boyé D.

Interferon. 1986;7:145-65. Review. No abstract available.

PMID:
2434432
46.

Effects of long-term treatment of human carcinoma cells with interferon alpha.

Brouty-Boyé D, Mogensen KE, Gresser I.

Eur J Cancer Clin Oncol. 1985 Apr;21(4):507-14.

PMID:
4040023
47.
48.

Fibrin clot retractile activity in normal, established, and tumorigenic human epithelial cells in culture.

Azzarone B, Macieira-Coelho A, Curatolo L, Brouty-Boyé D, Varnier O, Donati MB, Morasca L.

J Natl Cancer Inst. 1983 Nov;71(5):879-85.

PMID:
6580487

Supplemental Content

Loading ...
Support Center